BioSpace News Archive

The Parliamentary Secretary to the Minister of Health, Pam Damoff, will announce new support from the Government of Canada for Canadians living with Autism Spectrum Disorder and those who care for them.

Online mail-order pharmacy selected for “Healthcare in America” documentary

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today the acceptance of an oral late breaking presentation providing updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study as well as two poster presentations at the 17th International Myeloma Workshop (IMW) meeting (September 12-15, Boston, Massachusetts, USA).

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN).

For the first time in its 38-year history, Chicago-based AbelsonTaylor, one of the world’s premier health and wellness advertising agencies, has a new president

Pulse Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 48,000 shares of Pulse Biosciences common stock to six recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on August 15, 2019.

AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, has updated its list of limited distribution drugs announced Aug. 12.

The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.

SmileDirectClub announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of shares of its Class A common stock.

Cemvita Factory, a carbon-negative company, today announced that it has received equity investment from Oxy Low Carbon Ventures to support the commercialization of new bio-engineered pathways that use CO2 as the feedstock for sustainable production of intermediate chemicals and polymers.